FTISADTSK-13C6,15N2 TFA is 13C- and 15N-labeled FTISADTSK (HY-P3146). FTISADTSK is an endogenous stable signature peptide from Trastuzumab monitored by selected reaction monitoring (SRM)[1][2].
Molecular Weight:
1091.01
Purity:
96.04
Formula:
C38 13C6H69F3N8 15N2O18
Target:
Isotope-Labeled Compounds
Application Notes:
MCE Product type: Isotope-Labeled Compounds
* VAT and and shipping costs not included. Errors and price changes excepted